Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP719058.RAvEzU4TD7t3Owagz3yk7Bee0TG_SxbxTtfRCbH-G6PRw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP719058.RAvEzU4TD7t3Owagz3yk7Bee0TG_SxbxTtfRCbH-G6PRw130_assertion type Assertion NP719058.RAvEzU4TD7t3Owagz3yk7Bee0TG_SxbxTtfRCbH-G6PRw130_head.
- NP719058.RAvEzU4TD7t3Owagz3yk7Bee0TG_SxbxTtfRCbH-G6PRw130_assertion description "[To enhance the immunogenecity of CEA, we developed a fusion gene (CRT-TAT-DeltaCEA) of the TAT protein transduction domain (PTD) and calreticulin (CRT) with human CEA devoid of its signal sequences (DeltaCEA) and evaluated anti-tumor immunity using RNA-pulsed dendritic cell (DC) vaccination.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP719058.RAvEzU4TD7t3Owagz3yk7Bee0TG_SxbxTtfRCbH-G6PRw130_provenance.
- NP719058.RAvEzU4TD7t3Owagz3yk7Bee0TG_SxbxTtfRCbH-G6PRw130_assertion evidence source_evidence_literature NP719058.RAvEzU4TD7t3Owagz3yk7Bee0TG_SxbxTtfRCbH-G6PRw130_provenance.
- NP719058.RAvEzU4TD7t3Owagz3yk7Bee0TG_SxbxTtfRCbH-G6PRw130_assertion SIO_000772 18812201 NP719058.RAvEzU4TD7t3Owagz3yk7Bee0TG_SxbxTtfRCbH-G6PRw130_provenance.
- NP719058.RAvEzU4TD7t3Owagz3yk7Bee0TG_SxbxTtfRCbH-G6PRw130_assertion wasDerivedFrom befree-20140225 NP719058.RAvEzU4TD7t3Owagz3yk7Bee0TG_SxbxTtfRCbH-G6PRw130_provenance.
- NP719058.RAvEzU4TD7t3Owagz3yk7Bee0TG_SxbxTtfRCbH-G6PRw130_assertion wasGeneratedBy ECO_0000203 NP719058.RAvEzU4TD7t3Owagz3yk7Bee0TG_SxbxTtfRCbH-G6PRw130_provenance.